Growth Metrics

Nu-Med Plus (NUMD) Shareholder's Equity (QoQ) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nu-Med Plus - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -4.88%
Sep 30, 2025 -4.85%
Jun 30, 2025 -4.96%
Mar 31, 2025 -9.27%
Dec 31, 2024 -5.16%
Sep 30, 2024 -10.05%
Jun 30, 2024 -10.25%
Mar 31, 2024 -14.87%
Dec 31, 2023 -11.21%
Sep 30, 2023 -14.20%
Jun 30, 2023 -26.66%
Mar 31, 2023 -44.75%
Dec 31, 2022 76.67%
Sep 30, 2022 -9.33%
Jun 30, 2022 -30.72%
Mar 31, 2022 -42.80%
Dec 31, 2021 -89.04%
Sep 30, 2021 -4,140.88%
Jun 30, 2021 -100.86%
Mar 31, 2021 -59.17%
Dec 31, 2020 110.99%
Sep 30, 2020 -46.14%
Jun 30, 2020 212.05%
Mar 31, 2020 0.84%
Dec 31, 2019 -22.09%
Sep 30, 2019 1.25%
Jun 30, 2019 -36.76%
Mar 31, 2019 -562.98%
Dec 31, 2018 -75.05%
Sep 30, 2018 883.29%
Jun 30, 2018 -18.10%
Mar 31, 2018 -130.81%
Dec 31, 2017 51.73%
Sep 30, 2017 146.37%
Jun 30, 2017 -164.66%
Mar 31, 2017 99.17%
Dec 31, 2016 -3,149.66%
Sep 30, 2016 -123.65%
Jun 30, 2016 327.63%
Mar 31, 2016 98.33%
Dec 31, 2015 -6,947.74%
Sep 30, 2015 -16.80%
Jun 30, 2015 -5.10%
Mar 31, 2015 97.53%
Dec 31, 2014 -13,128.05%
Sep 30, 2014 -118.90%
Jun 30, 2014 16.54%
Mar 31, 2014 296.29%
Dec 31, 2013 14.66%
Sep 30, 2013 11.64%
Jun 30, 2013 -28.08%
Mar 31, 2013 -179.36%